Table 2b.
BBB MODEL | CONDITION | Donor 1 | Donor 2 | Donor 3 | Donor 4 | Donor 5 | p-value* |
---|---|---|---|---|---|---|---|
INPUT | 22.7 | 22.6 | 37.9 | 28.8 | 46.1 | n/a | |
Basal IVBBB | No Chemokine-Non-migrated | 23.0 | 21.4 | 32.9 | 28.7 | 44.0 | n.s. |
Basal IVBBB | No Chemokine-Migrated | 23.6 | 23.0 | 36.4 | 30.6 | 49.7 | n.s. |
Basal IVBBB | + CCL5-Non-migrated | 20.3 | 21.3 | 37.0 | 27.3 | 44.0 | n.s. |
Basal IVBBB | + CCL5-Migrated | 20.7 | 21.9 | 33.2 | 28.1 | 45.8 | n.s. |
aIVBBB | No Chemokine-Non-migrated | 23.5 | 21.6 | 36.9 | 27.9 | 44.3 | n.s. |
aIVBBB | No Chemokine-Migrated | 23.4 | 21.1 | 34.8 | 30.4 | 42.2 | n.s. |
aIVBBB | + CCL5-Non-migrated | 22.4 | 22.0 | 37.2 | 28.0 | 43.8 | n.s. |
aIVBBB | + CCL5-Migrated | 20.7 | 20.8 | 37.4 | 26.2 | 45.1 | n.s. |
indicates that p-values were ascertained relative to the input MFI. Key: aIVBBB: cytokine-activated in vitro blood-brain barrier, IVBBB: in vitro blood-brain barrier, n/a: not applicable, n.s.: not significant.